Article
Impact of the CYP3A5, CYP3A4, COMT, IL-10 and POR genetic polymorphisms on tacrolimus metabolism in Chinese renal transplant recipients.
PloS one - 1 Jan 2014
Li Chuan-Jiang, Li Liang, Lin Li, Jiang Hai-Xia, Zhong Ze-Yan, Li Wei-Mo, Zhang Yan-Jun, Zheng Ping, Tan Xu-Hui, Zhou Lin
Abstract excerpt
Tacrolimus is a widely used immunosuppressive drug for preventing the rejection of solid organ transplants. The efficacy of tacrolimus shows considerable variability, which might be related to genetic variation among recipients. We conducted a retrospective study of 240 Chinese renal transplant recipients receiving tacrolimus as immunosuppressive drug. The retrospective data of all patients were collected for 40...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
